Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co., Ltd., established in 1913, is a prominent Japanese pharmaceutical company dedicated to the research and development of innovative medicinal products. Operating within the Healthcare and Pharmaceuticals sectors, the company has consistently provided distinctive treatments to the medical field. Its long-standing commitment to scientific advancement underpins its mission to address evolving healthcare needs.

The company's core pharmaceutical business strategically focuses its resources on key therapeutic areas, including cardiovascular medicine, obstetrics and gynecology, psychiatry, and gastroenterology. Beyond these targeted areas, Mochida Pharmaceutical Co., Ltd. also develops and supplies medicines for intractable diseases, alongside a portfolio of generics and biosimilars, ensuring comprehensive medical coverage. With an employee range of 1,000 - 5,000 individuals, the organization fosters a dedicated workforce. Meet Mochida Pharmaceutical Co., Ltd.'s team to gain insight into their leadership and operational structure.

As a publicly held entity, Mochida Pharmaceutical Co., Ltd. trades under the ticker TYO: MFY. Its operations are centered in Tokyo, Japan, contributing to the Asian pharmaceutical landscape. The company's ongoing investment in R&D drives its pipeline of novel therapies and essential generic medications, reinforcing its position as a key player in delivering advanced healthcare solutions and meeting diverse patient requirements.